melarsoprol has been researched along with Acanthamoeba Meningoencephalitis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blum, J; Burri, C; Schmid, C | 1 |
| Blum, J; Burri, C; Nkunku, S | 1 |
2 trial(s) available for melarsoprol and Acanthamoeba Meningoencephalitis
| Article | Year |
|---|---|
Clinical aspects of 2541 patients with second stage human African trypanosomiasis.
Topics: Adolescent; Adult; Animals; Central Nervous System Protozoal Infections; Child; Child, Preschool; Female; Headache; Humans; Incidence; Infant; Internationality; Lymphatic Diseases; Male; Melarsoprol; Prospective Studies; Pruritus; Surveys and Questionnaires; Trypanocidal Agents; Trypanosomiasis, African | 2006 |
Clinical description of encephalopathic syndromes and risk factors for their occurrence and outcome during melarsoprol treatment of human African trypanosomiasis.
Topics: Adult; Angola; Central Nervous System Protozoal Infections; Drug Administration Schedule; Female; Humans; Male; Melarsoprol; Middle Aged; Predictive Value of Tests; Risk Factors; Syndrome; Time Factors; Treatment Outcome; Trypanocidal Agents; Trypanosomiasis, African | 2001 |